Me-CCNU

DRUG2 trials

Sponsors

First Affiliated Hospital of Zhejiang University, Yi Luo

Conditions

Graft-versus-host-diseaseLeukemia

Phase 2

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Yi LuoGraft-versus-host-disease, Leukemia

Start: 2020-12-03End: 2024-12-31Target: 46Updated: 2023-02-21

Phase 3

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

RecruitingNCT04547049

First Affiliated Hospital of Zhejiang UniversityLeukemia

Start: 2020-09-01End: 2025-12-31Target: 176Updated: 2025-03-25